• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Stimulation of pancreatic secretion in man by a protease inhibitor (camostate).

作者信息

Adler G, Müllenhoff A, Koop I, Bozkurt T, Göke B, Beglinger C, Arnold R

机构信息

Department of Internal Medicine, University of Marburg, FRG.

出版信息

Eur J Clin Invest. 1988 Feb;18(1):98-104. doi: 10.1111/j.1365-2362.1988.tb01173.x.

DOI:10.1111/j.1365-2362.1988.tb01173.x
PMID:3130267
Abstract

Pancreatic secretion and plasma cholecystokinin (CCK) and secretin levels were measured in 10 healthy volunteers after application of a serine protease inhibitor (camostate) to study the mechanism of feedback regulation. Camostate produced a strong inhibition of trypsin and chymotrypsin activity in duodenal juice for 1 h. This was accompanied by an increase in duodenal aspirate volume and pancreatic enzyme secretion under both basal and secretin-stimulated conditions. Due to inhibition of tryptic activity, survival of lipase activity in duodenal juice was prolonged. In control experiments we ruled out that the volume and the pH of the solution were responsible for stimulation of pancreatic secretion. The protease inhibitor did not alter pancreatic secretion, which was stimulated by a test meal. Plasma levels of CCK and secretin were not changed after duodenal perfusion of camostate. These observations suggest that trypsin and chymotrypsin are involved in feedback regulation of pancreatic secretion in man which is, however, not mediated by CCK or secretin.

摘要

相似文献

1
Stimulation of pancreatic secretion in man by a protease inhibitor (camostate).
Eur J Clin Invest. 1988 Feb;18(1):98-104. doi: 10.1111/j.1365-2362.1988.tb01173.x.
2
Comparison of the effect of single and repeated administrations of a protease inhibitor (Camostate) on pancreatic secretion in man.
Scand J Gastroenterol. 1988 Mar;23(2):158-62. doi: 10.3109/00365528809103961.
3
Differential effects of atropine and a cholecystokinin receptor antagonist on pancreatic secretion.阿托品与胆囊收缩素受体拮抗剂对胰腺分泌的不同作用
Gastroenterology. 1989 Apr;96(4):1158-64. doi: 10.1016/0016-5085(89)91636-3.
4
Adaptation of the human pancreas to inhibition of luminal proteolytic activity.
Gastroenterology. 1998 Aug;115(2):388-96. doi: 10.1016/s0016-5085(98)70205-7.
5
Effect of atropine on feedback regulation of pancreatic secretion in rats.阿托品对大鼠胰腺分泌反馈调节的影响。
Res Exp Med (Berl). 1989;189(3):221-8. doi: 10.1007/BF01852170.
6
Feedback regulation of human pancreatic secretion. Effects of protease inhibition on duodenal delivery and small intestinal transit of pancreatic enzymes.人胰腺分泌的反馈调节。蛋白酶抑制对胰腺酶十二指肠输送和小肠转运的影响。
Gastroenterology. 1990 May;98(5 Pt 1):1311-9.
7
Effect of a specific serine protease inhibitor on the rat pancreas: systemic administration of camostate and exocrine pancreatic secretion.一种特异性丝氨酸蛋白酶抑制剂对大鼠胰腺的作用:抑肽酶的全身给药与胰腺外分泌
Digestion. 1984;30(3):171-8. doi: 10.1159/000199102.
8
Effects of trypsin inhibitor (camostate) on pancreas and CCK release in young and old female rats.
J Gerontol. 1989 Jul;44(4):M136-40. doi: 10.1093/geronj/44.4.m136.
9
Different effects of trypsin inhibitors on intestinal gene expression of secretin and on pancreatic bicarbonate secretion in CCK-A-receptor-deficient rats.胰蛋白酶抑制剂对CCK-A受体缺陷型大鼠肠道促胰液素基因表达及胰腺碳酸氢盐分泌的不同影响。
Jpn J Pharmacol. 1999 Dec;81(4):339-45. doi: 10.1254/jjp.81.339.
10
Pancreatic growth: interaction of exogenous cholecystokinin, a protease inhibitor, and a cholecystokinin receptor antagonist in mice.胰腺生长:外源性胆囊收缩素、一种蛋白酶抑制剂和一种胆囊收缩素受体拮抗剂在小鼠体内的相互作用
Gut. 1987;28 Suppl(Suppl):63-9. doi: 10.1136/gut.28.suppl.63.

引用本文的文献

1
Molecular mechanisms involved in anosmia induced by SARS-CoV-2, with a focus on the transmembrane serine protease TMPRSS2.SARS-CoV-2 引起嗅觉丧失的分子机制,重点关注跨膜丝氨酸蛋白酶 TMPRSS2。
Arch Virol. 2022 Oct;167(10):1931-1946. doi: 10.1007/s00705-022-05545-0. Epub 2022 Aug 8.
2
Candidate drugs against SARS-CoV-2 and COVID-19.针对 SARS-CoV-2 和 COVID-19 的候选药物。
Pharmacol Res. 2020 Jul;157:104859. doi: 10.1016/j.phrs.2020.104859. Epub 2020 Apr 29.
3
Management of pain in chronic pancreatitis with emphasis on exogenous pancreatic enzymes.
慢性胰腺炎疼痛的管理,重点关注外源性胰酶
World J Gastrointest Pharmacol Ther. 2016 Aug 6;7(3):370-86. doi: 10.4292/wjgpt.v7.i3.370.
4
Enzyme replacement therapy for pancreatic insufficiency: present and future.用于胰腺功能不全的酶替代疗法:现状与未来。
Clin Exp Gastroenterol. 2011;4:55-73. doi: 10.2147/CEG.S17634. Epub 2011 May 4.
5
Chronic diversion of bile to the urinary bladder induces pancreatic growth in dogs.长期将胆汁引流至膀胱会导致犬胰腺生长。
J Gastrointest Surg. 2000 Sep-Oct;4(5):513-9. doi: 10.1016/s1091-255x(00)80094-3.
6
Influence of high-dose pancreatic enzyme treatment on pancreatic function in healthy volunteers.
Int J Pancreatol. 1998 Apr;23(2):115-23. doi: 10.1385/IJGC:23:2:115.
7
No negative feedback regulation between plasma CCK levels and luminal tryptic activities in patients with pancreatic insufficiency.胰腺功能不全患者血浆胆囊收缩素水平与腔内胰蛋白酶活性之间不存在负反馈调节。
Int J Pancreatol. 1995 Feb;17(1):29-35. doi: 10.1007/BF02788356.
8
Gastrin-releasing peptide and CCK after intraduodenal inhibition of proteases in dogs.十二指肠内抑制犬蛋白酶后胃泌素释放肽与胆囊收缩素的变化
Int J Pancreatol. 1994 Jun;15(3):209-14. doi: 10.1007/BF02924196.
9
Lack of effect of the specific cholecystokinin receptor antagonist loxiglumide on cholecystokinin clearance from plasma in man.特异性胆囊收缩素受体拮抗剂洛西肽胺对人体血浆中胆囊收缩素清除率无影响。
Br J Clin Pharmacol. 1990 Jun;29(6):770-3. doi: 10.1111/j.1365-2125.1990.tb03701.x.
10
Perspectives of CCK antagonists in pancreatic research and clinical use. Part I.CCK拮抗剂在胰腺研究及临床应用中的前景。第一部分。
Int J Pancreatol. 1991 Apr;8(3):215-26. doi: 10.1007/BF02924540.